Contraception in Women with Migraine with Aura
Combined oral contraceptives (COCs) are contraindicated in women with migraine with aura due to significantly increased stroke risk, and this 27-year-old female should be switched to a progestin-only pill or other non-estrogen containing contraceptive method. 1
Risk Assessment
Migraine with aura independently increases ischemic stroke risk (RR 2.16; 95% CI, 1.53-3.03) 1. When combined with COC use, this risk increases dramatically:
- Meta-analyses show that oral contraceptive use in women with migraine with aura increases ischemic stroke risk by 7-fold (RR 7.02; 95% CI, 1.51–32.68) 1
- The American Heart Association/American Stroke Association 2024 guidelines clearly state that for individuals with specific stroke risk factors including migraine with aura, progestin-only contraception or nonhormonal contraception is reasonable to prevent the increased stroke risk associated with estrogen-containing contraception 2
Recommended Contraceptive Options
For this 27-year-old woman with migraine with aura, the following options are appropriate:
- Progestin-only pills (POPs) - Safe with no increased stroke risk 1, 3
- Long-acting reversible contraceptives:
- Levonorgestrel intrauterine device
- Etonogestrel implant
- Depot medroxyprogesterone acetate injections
- Non-hormonal methods:
- Copper IUD
- Barrier methods
- Fertility awareness methods
How to Switch from COC to POP
To switch this patient from a combined oral contraceptive to a progestin-only pill:
- Immediate transition: Have the patient start the progestin-only pill (such as norethindrone 0.35mg or desogestrel 75mcg) the day after taking the last active COC pill
- No hormone-free interval: Unlike COCs, POPs are taken continuously without breaks
- Consistent timing: Advise taking the POP at the same time each day (within a 3-hour window) for optimal efficacy
- Backup contraception: Use backup contraception (condoms) for the first 48 hours after switching
- Bleeding pattern expectations: Inform the patient that irregular bleeding patterns are common with POPs, especially in the first few months 3
Benefits of Progestin-Only Methods
Beyond safety, progestin-only methods may offer additional benefits for migraine patients:
- Research shows that desogestrel-containing POPs may actually reduce the number of migraine attacks and potentially improve aura symptoms 4
- POPs avoid the estrogen withdrawal that can trigger headaches in some women 5
Important Monitoring Considerations
Regular follow-up: Schedule follow-up at 3 months to assess:
- Contraceptive efficacy and adherence
- Changes in migraine pattern
- Bleeding patterns
- Side effects
Warning signs requiring immediate attention:
- Worsening headache pattern
- New focal neurological symptoms
- Signs of stroke (facial drooping, arm weakness, speech difficulties)
Common Pitfalls to Avoid
Misinterpreting newer research: Some recent studies suggest that newer, lower-dose COCs may have less stroke risk 6, 7. However, the most recent guidelines from the American Heart Association/American Stroke Association (2024) still contraindicate estrogen-containing contraceptives in women with migraine with aura 2
Inconsistent POP timing: Unlike COCs, POPs have a narrower window for effectiveness (typically 3 hours). Emphasize the importance of consistent timing to maintain contraceptive efficacy
Ignoring additional risk factors: Assess for other stroke risk factors that would further increase risk (smoking, hypertension, age >35 years) 2, 1
By following these recommendations, you can provide safe and effective contraception for this 27-year-old woman with migraine with aura while minimizing her stroke risk.